We are live on ! Find out more
CHTP

Chelsea Therapeutics International
CHTP

Delisted

CHTP was delisted on the 23rd of June, 2014.

6 hedge funds and large institutions have $4.84M invested in Chelsea Therapeutics International in 2014 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 4 reducing their positions, and 81 closing their positions.

New
Increased
Maintained
Reduced
Closed

379% more call options, than puts

Call options by funds: $13.8M | Put options by funds: $2.87M

90% less capital inflows, than outflows

Capital inflows: $20.8M | Capital outflows: $202M

93% less funds holding

Funds holding: 85 → 6 (-79)

98% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 81

100% less funds holding in top 10

Funds holding in top 10: 2 → 0 (-2)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 4

Holders
6
Holders Change
-79
Holders Change %
-92.94%
% of All Funds
0.17%
Holding in Top 10
–
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
–
New
2
Increased
–
Reduced
4
Closed
81
Calls
$13.8M
Puts
$2.87M
Net Calls
+$10.9M
Net Calls Change
+$4.71M

CHTP Hedge Fund Activity: Q2 2014 in Review

6 of the 3,491 institutional investors tracked by Wall St. Rank reported a position in Chelsea Therapeutics International (CHTP) for Q2 2014, worth a combined $4.84M — down 98% from $204M a quarter earlier.

Sellers outnumbered buyers: 81 funds closed out of CHTP and 2 opened new positions — a net loss of 79 holders — while 4 trimmed existing stakes and 0 added.

The largest buyer was Whitebox Advisors, opening a new position worth an estimated $16.4M. The largest seller was Baker Bros. Advisors, exiting entirely with an estimated $37.3M sold.

  • 6 institutional investors held Chelsea Therapeutics International (CHTP) as of Q2 2014, down from 85 in Q1 2014.
  • Funds reported $4.84M of Chelsea Therapeutics International stock for Q2 2014, down 98% quarter-over-quarter.
  • 2 funds opened new Chelsea Therapeutics International positions in Q2 2014 and 81 closed out, a net change of -79 holders.
  • The largest Chelsea Therapeutics International buyer in Q2 2014 was Whitebox Advisors, an estimated $16.4M added.
  • The largest Chelsea Therapeutics International seller in Q2 2014 was Baker Bros. Advisors, an estimated $37.3M sold.

Based on aggregated 13F filings for Q2 2014.